Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis (Q28297061)

4

object named as

Stacey W Martin

0 references

Carlos G. Grijalva

1

object named as

Carlos G Grijalva

0 references

Marie R. Griffin

6

object named as

Marie R Griffin

0 references

author name string

J Pekka Nuorti

2

0 references

Patrick G Arbogast

Community-acquired pneumonia in children

3

0 references

language of work or name

English

0 references

publication date

7 April 2007

0 references

published in

The Lancet

0 references

volume

369

0 references

page(s)

1179-86

0 references

issue

9568

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Pneumonia: the leading killer of children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

The burden of pneumonia in children in the developed world.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

The burden of community-acquired pneumonia in seniors: results of a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Community acquired pneumonia--a prospective UK study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Population-based impact of pneumococcal conjugate vaccine in young children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Segmented regression analysis of interrupted time series studies in medication use research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

A role for Streptococcus pneumoniae in virus-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

The potential indirect effect of conjugate pneumococcal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

The Gambian pneumococcal vaccine trial - implications for control of childhood pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Evidence of bias in estimates of influenza vaccine effectiveness in seniors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Explaining trends in hospitalizations for pneumonia and influenza in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Promises and challenges of pneumococcal conjugate vaccines for the developing world

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021

Pneumococcal vaccination in developing countries.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960564-9

7 January 2021